These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25077404)

  • 21. Clinical controversy: to treat, or not to treat? That is the tuberculosis question.
    Troutbeck R; Lim LL
    Clin Exp Ophthalmol; 2012; 40(7):653-4. PubMed ID: 23046170
    [No Abstract]   [Full Text] [Related]  

  • 22. Potential of interferon-γ-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients.
    Aabye MG; Ruhwald M; Praygod G; Jeremiah K; Faurholt-Jepsen M; Faurholt-Jepsen D; Range N; Friis H; Changalucha J; Andersen AB; Ravn P
    Eur Respir J; 2010 Dec; 36(6):1488-90. PubMed ID: 21119209
    [No Abstract]   [Full Text] [Related]  

  • 23. Latent tuberculosis infection as a target for tuberculosis control.
    van Leth F; van Crevel R; Brouwer M
    Future Microbiol; 2015; 10(6):905-8. PubMed ID: 26059614
    [No Abstract]   [Full Text] [Related]  

  • 24. Bifunctional T-cell-derived cytokines for the diagnosis of tuberculosis and treatment monitoring.
    Essone PN; Kalsdorf B; Chegou NN; Loxton AG; Kriel M; Preyer R; Ernst M; Walzl G; Lange C
    Respiration; 2014; 88(3):251-61. PubMed ID: 25171202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exaggerated Mantoux reaction in a case of latent tuberculosis infection (LTBI).
    Bansal R; Sharma PK
    Indian J Tuberc; 2012 Jul; 59(3):171-3. PubMed ID: 23362716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three air travel-related contact investigations associated with infectious tuberculosis, 2007-2008.
    Kornylo-Duong K; Kim C; Cramer EH; Buff AM; Rodriguez-Howell D; Doyle J; Higashi J; Fruthaler CS; Robertson CL; Marienau KJ
    Travel Med Infect Dis; 2010 Mar; 8(2):120-8. PubMed ID: 20478520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection.
    Keshavjee S; Amanullah F; Cattamanchi A; Chaisson R; Dobos KM; Fox GJ; Gendelman HE; Gordon R; Hesseling A; Le Van H; Kampmann B; Kana B; Khuller G; Lewinsohn DM; Lewinsohn DA; Lin PL; Lu LL; Maartens G; Owen A; Protopopova M; Rengarajan J; Rubin E; Salgame P; Schurr E; Seddon JA; Swindells S; Tobin DM; Udwadia Z; Walzl G; Srinivasan S; Rustomjee R; Nahid P
    Am J Respir Crit Care Med; 2019 Mar; 199(5):564-571. PubMed ID: 30335466
    [No Abstract]   [Full Text] [Related]  

  • 28. What do we know about the outcomes of tuberculosis contact investigations in NSW?
    Dobler CC
    N S W Public Health Bull; 2013 Jul; 24(1):34-7. PubMed ID: 23849028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serial interferon-γ release assay in children with latent tuberculosis infection and children with tuberculosis.
    Nenadić N; Kirin BK; Letoja IZ; Plavec D; Topić RZ; Dodig S
    Pediatr Pulmonol; 2012 Apr; 47(4):401-8. PubMed ID: 21901862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges in diagnosis and treatment of latent tuberculosis infection.
    Gupta KB
    Indian J Tuberc; 2012 Jan; 59(1):1-5. PubMed ID: 22670504
    [No Abstract]   [Full Text] [Related]  

  • 31. Programmatic impact of using QuantiFERON®-TB Gold in routine contact investigation activities.
    Grinsdale JA; Ho CS; Banouvong H; Kawamura LM
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1614-20. PubMed ID: 22118167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active and latent tuberculosis in prisoners in the Central-West Region of Brazil.
    Estevan AO; Oliveira SM; Croda J
    Rev Soc Bras Med Trop; 2013; 46(4):515-8. PubMed ID: 23904084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevention of secondary tuberculosis in the contact tracing].
    Matsumoto K; Shimouchi A
    Kekkaku; 2011 Nov; 86(11):889-90. PubMed ID: 22295434
    [No Abstract]   [Full Text] [Related]  

  • 34. Scoring system, recommended by the Brazilian National Ministry of Health, for the diagnosis of pulmonary tuberculosis.
    Wiwanitkit V
    J Bras Pneumol; 2010; 36(3):394; author reply 396. PubMed ID: 20625679
    [No Abstract]   [Full Text] [Related]  

  • 35. Who misses the second step of evaluation in tuberculosis contact screening?
    Soares Pires F; Pinto C; Duarte R
    Eur Respir J; 2011 Aug; 38(2):474-6. PubMed ID: 21804166
    [No Abstract]   [Full Text] [Related]  

  • 36. Metronidazole validates drugs targeting hypoxic bacteria for improved treatment of tuberculosis.
    Zhang Y
    Proc Natl Acad Sci U S A; 2012 Aug; 109(35):13890-1. PubMed ID: 22895789
    [No Abstract]   [Full Text] [Related]  

  • 37. Ethnicity-tailored novel set of ESAT-6 peptides for differentiating active and latent tuberculosis.
    Singh SB; Biswas D; Rawat J; Sindhwani G; Patras A; Devrani S; Sarkar P; Mitra S; Gupta SK
    Tuberculosis (Edinb); 2013 Nov; 93(6):618-24. PubMed ID: 24011630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. To eliminate tuberculosis, we must universally encourage treatment of its latent form.
    Schraufnagel DE
    Respirology; 2015 Aug; 20(6):851-4. PubMed ID: 26172202
    [No Abstract]   [Full Text] [Related]  

  • 39. Discriminating between latent and active tuberculosis: the role of interleukin-2 as biomarker.
    Mamishi S; Pourakbari B; Marjani M; Bahador A; Mahmoudi S
    J Infect; 2015 Apr; 70(4):429-31. PubMed ID: 25562449
    [No Abstract]   [Full Text] [Related]  

  • 40. Latent tuberculosis infection among close contacts of multidrug-resistant tuberculosis patients in central Taiwan.
    Huang YW; Shen GH; Lee JJ; Yang WT
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1430-5. PubMed ID: 20937183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.